应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SVA 科兴生物
停牌 05-09 07:00:21 EDT
6.47
+0.00
0.00%
最高
6.47
最低
6.47
成交量
0.00
今开
6.47
昨收
6.47
日振幅
0.00%
总市值
6.42亿
流通市值
3.85亿
总股本
9,929万
成交额
0.00
换手率
0.00%
流通股本
5,951万
市净率
0.86
ROE
25.15%
每股收益
0.97
52周最高
6.47
52周最低
6.47
市盈率
6.66
股息
0.00
股息收益率
0.00
ROA
11.46%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
科兴生物:股权争夺与审计风波 8亿美元股息
和讯网 · 04-30
科兴生物:股权争夺与审计风波 8亿美元股息
科兴新董事会回应维梧资本“炮轰”
界面 · 04-30
科兴新董事会回应维梧资本“炮轰”
北京科兴生物制品有限公司中标包头海关综合技术服务中心供货合同
iDoNews · 04-29
北京科兴生物制品有限公司中标包头海关综合技术服务中心供货合同
新事 | 科兴生物被起诉
健识局 · 04-25
新事 | 科兴生物被起诉
科兴控股:2025—2026年流感季流感疫苗率先获批上市
美港电讯 · 04-17
科兴控股:2025—2026年流感季流感疫苗率先获批上市
【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上,科兴副总裁、国际业务负责人孟伟宁介绍,1月10号,SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标,首批疫苗将于1月15日发往智利。
金融界 · 01-14
【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上,科兴副总裁、国际业务负责人孟伟宁介绍,1月10号,SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标,首批疫苗将于1月15日发往智利。
加载更多
公司概况
公司名称:
科兴生物
所属市场:
NASDAQ
上市日期:
2004-12-08
主营业务:
科兴控股生物技术有限公司于1999年3月1日在安提瓜和巴布达注册成立,是一家总部位于北京的生物高新技术企业。公司主要从事于研究,开发,制造及保护免受感染性疾病的疫苗。公司还曾先后研制出全球第一支SARS冠状病毒灭活疫苗(完成I期临床研究)、中国第一支大流行流感(H5N1)疫苗以及全球第一支甲型H1N1流感疫苗,为中国乃至全球疾病预防控制做出了贡献。公司正在开发一系列新产品,包括Sabin株脊髓灰质炎灭活疫苗、23价肺炎球菌多糖疫苗、新型冠状病毒灭活疫苗及多个联合疫苗等。
发行价格:
--
{"stockData":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"科兴生物","latestPrice":6.47,"timestamp":1746734400000,"preClose":6.47,"halted":3,"volume":0,"delay":0,"floatShares":59508401,"shares":99294743,"eps":0.971025,"marketStatus":"停牌","change":0,"latestTime":"05-09 07:00:19 EDT","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.971025,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746797400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1102482000000,"exchange":"NASDAQ","adjPreClose":6.47,"volumeRatio":0.5219117885997689},"requestUrl":"/m/hq/s/SVA","defaultTab":"news","newsList":[{"id":"2531777680","title":"科兴生物:股权争夺与审计风波 8亿美元股息","url":"https://stock-news.laohu8.com/highlight/detail?id=2531777680","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531777680?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:37","pubTimestamp":1745995069,"startTime":"0","endTime":"0","summary":"【4 月 29 日,国内著名疫苗厂商科兴生物与维梧资本陷纷争】科兴生物称维梧资本此前言论为虚假指控,维梧集团正通过诉讼等方式试图阻止公司向股东支付特别股息。科兴生物指出所有普通股股东过去七年分文未得,而维梧集团已从科兴一家控股子公司获超 8 亿美元现金股息。科兴生物认为维梧集团行为动机为谋财,其主张与法院裁决相悖。科兴生物的股权争夺战可追溯至 2016 年。维梧资本 4 月 24 日称已对科兴生物发起诉讼,审计师辞职致科兴生物无法按期提交年度报告。4 月 29 日科兴生物称审计师辞职原因在于无法依赖此前财务状况陈述,公司已增添审计委员会财务专家。(责任编辑:张晓波 )","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430144525a6ce69b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430144525a6ce69b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2531724393","title":"科兴新董事会回应维梧资本“炮轰”","url":"https://stock-news.laohu8.com/highlight/detail?id=2531724393","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531724393?lang=zh_cn&edition=full","pubTime":"2025-04-30 11:41","pubTimestamp":1745984501,"startTime":"0","endTime":"0","summary":"简单理解,维梧资本代表的是科兴生物前董事会的利益,科兴生物当前的发文代表的是新董事会的决策。维梧资本目前将1 Globe视为“激进投资人”,认为“1 Globe及其控制下的董事会(会)进一步采取破坏性行动”。在科兴生物4月29日发文之前,4月24日,维梧资本在公众号发文称,公司已对科兴生物董事会发起诉讼。维梧资本认为,科兴生物董事会在1Globe及其盟友控制下,采取了诸多不负责任行为。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430114459a46d18a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430114459a46d18a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SQQQ","TQQQ","TSYW.SI","USAW.SI","QID",".IXIC","ARTL","NVIW.SI","NQmain","QLD","USJW.SI","BK4139","PSQ","BK4007","SVA","MNQmain"],"gpt_icon":1},{"id":"2531001562","title":"北京科兴生物制品有限公司中标包头海关综合技术服务中心供货合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2531001562","media":"iDoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531001562?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:23","pubTimestamp":1745922182,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年04月28日,北京科兴生物制品有限公司中标包头海关综合技术服务中心的供货合同项目。该项目为海关总署2023-2024年出入境预防接种疫苗询价(重新招标)采购项目,合同金额为0.616000万元。合同主要信息显示,标的物为四价流感疫苗,规格型号为注射器包装,数量70个,单价88元。履约地点为内蒙古自治区包头市昆区少先路18号的包头海关综合技术服务中心,合同签订日期为2025年04月25日,公告类型为中标结果。免责声明:本文内容由开放的智能模型自动生成,仅供参考。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918234894e760d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918234894e760d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2530303180","title":"新事 | 科兴生物被起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2530303180","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530303180?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:08","pubTimestamp":1745582937,"startTime":"0","endTime":"0","summary":"4月28日,维梧资本发布公告称:公司已对科兴控股生物技术有限公司的发起诉讼。双方争论的焦点是:科兴生物改变董事会人选之后,管理层作出一系列变化引发公司治理危机。为此,维梧资本在美国多地高等法院对科兴生物提起诉讼,要求法院下令禁止1 Globe进一步违反美国证券法,并强制其披露关于科兴生物的计划和相关方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425202525a466d40b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425202525a466d40b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2528216754","title":"科兴控股:2025—2026年流感季流感疫苗率先获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2528216754","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528216754?lang=zh_cn&edition=full","pubTime":"2025-04-17 15:04","pubTimestamp":1744873444,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4139","BK1549","SVA","BK1200","159646","00506"],"gpt_icon":0},{"id":"2503545080","title":"【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上,科兴副总裁、国际业务负责人孟伟宁介绍,1月10号,SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标,首批疫苗将于1月15日发往智利。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503545080","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503545080?lang=zh_cn&edition=full","pubTime":"2025-01-14 16:59","pubTimestamp":1736845176,"startTime":"0","endTime":"0","summary":"SINOVAC科兴中标智利项目新闻发布会上,科兴副总裁、国际业务负责人孟伟宁介绍,1月10号,SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标,首批疫苗将于1月15日发往智利。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/14165947435781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159646","BK4139","SVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinovac.com;www.sinovac.com.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0118},{"period":"1month","weight":0.1381},{"period":"3month","weight":-0.0594},{"period":"6month","weight":-0.0554},{"period":"1year","weight":0.0926},{"period":"ytd","weight":-0.0359}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"科兴控股生物技术有限公司于1999年3月1日在安提瓜和巴布达注册成立,是一家总部位于北京的生物高新技术企业。公司主要从事于研究,开发,制造及保护免受感染性疾病的疫苗。公司还曾先后研制出全球第一支SARS冠状病毒灭活疫苗(完成I期临床研究)、中国第一支大流行流感(H5N1)疫苗以及全球第一支甲型H1N1流感疫苗,为中国乃至全球疾病预防控制做出了贡献。公司正在开发一系列新产品,包括Sabin株脊髓灰质炎灭活疫苗、23价肺炎球菌多糖疫苗、新型冠状病毒灭活疫苗及多个联合疫苗等。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.027083},{"month":2,"riseRate":0.7,"avgChangeRate":0.044011},{"month":3,"riseRate":0.777778,"avgChangeRate":0.016157},{"month":4,"riseRate":0.111111,"avgChangeRate":-0.050461},{"month":5,"riseRate":0.4,"avgChangeRate":-0.030864},{"month":6,"riseRate":0.444444,"avgChangeRate":0.023452},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.027021},{"month":8,"riseRate":0.444444,"avgChangeRate":0.025862},{"month":9,"riseRate":0.666667,"avgChangeRate":0.007361},{"month":10,"riseRate":0.666667,"avgChangeRate":0.018455},{"month":11,"riseRate":0.666667,"avgChangeRate":0.055242},{"month":12,"riseRate":0.3,"avgChangeRate":-0.010006}],"exchange":"NASDAQ","name":"科兴生物","nameEN":"Sinovac Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科兴生物,SVA,科兴生物股票,科兴生物股票老虎,科兴生物股票老虎国际,科兴生物行情,科兴生物股票行情,科兴生物股价,科兴生物股市,科兴生物股票价格,科兴生物股票交易,科兴生物股票购买,科兴生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}